The Hartford Global Health Fund	View Daily Fund Prices (NAV)

Investment Goal
The fund seeks long-term capital appreciation by investing in stocks of health care companies worldwide.

top of page ^

Investment Approach
The fund uses the bottom-up fundamental research of companies worldwide involved in the following:

• Medical products
• Medical services
• Major pharmaceuticals
• Specialty pharmaceuticals including biotechnology

• New product development
• Consolidations
• Regulatory and political changes

top of page ^

PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. Current Performance may be lower or higher than the performance data quoted. For performance current to the most recent month ended, please see www.hartfordadvisor.com.

The investment return and principal value of an investment will fluctuate so that shares, when redeemed, may be worth more or less than their original cost.

Excluding sales charge
As of 10/31/2008 - Monthly						All returns in percentages
		Total					Annualized
	Inception	Return	Average Annual Total Return				Return
Class	Date	Ytd	1YR	3YR	5YR	10YR	(Since inception)
A	05/01/2000	-26.14%	-27.59%	-2.90%	2.94%	----	6.75%
B	05/01/2000	-26.67%	-28.17%	-3.71%	2.15%	----	5.94%
C	05/01/2000	-26.56%	-28.10%	-3.60%	2.20%	----	5.98%

Sales charge adjusted*
As of 10/31/2008 - Monthly						All returns in percentages
						Annualized
	Inception	Average Annual Total Return				Return	Current
Class	Date	1YR	3YR	5YR	10YR	(Since inception)	Yield
A	05/01/2000	-31.57%	-4.71%	1.79%	----	6.04%	---
B	05/01/2000	-31.49%	-4.51%	1.83%	----	5.94%	---
C	05/01/2000	-28.77%	-3.60%	2.20%	----	5.98%	---

Sales charge adjusted*
As of 09/30/2008 - Quarterly						All returns in percentages
						Annualized
	Inception	Average Annual Total Return				Return	Current
Class	Date	1YR	3YR	5YR	10YR	(Since inception)	Yield
A	05/01/2000	-16.44%	0.63%	6.29%	----	8.59%	---
B	05/01/2000	-16.43%	0.85%	6.35%	----	8.49%	---
C	05/01/2000	-13.05%	1.79%	6.71%	----	8.53%	---

PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. Current Performance may be lower or higher than the performance data quoted. For performance current to the most recent month ended, please see www.hartfordadvisor.com. The investment return and principal value of an investment will fluctuate so that shares, when redeemed, may be worth more or less than their original cost.

* Performance Including Maximum Sales Charge- The maximum sales charge for Class A shares is 5.5% (Except: 4.5% for High Yield, Income, Total Return Bond, Tax- Free MN, Tax- Free CA, Tax- Free NY, Tax- Free National, U.S. Government Securities, and the Inflation Plus Fund. 3.0% for Short Duration, and no sales charge for the Money Market Fund). Class B shares reflect the deduction of the contingent deferred sales charge (CDSC) in years one through six of 5%, 4%, 3%, 3%, 2%, and 1% respectively. Class C shares reflect a 1% CDSC in year one.

top of page ^

top of page ^

top of page ^

top of page ^

top of page ^

Portfolio Managers

Joseph H. Schwartz, CFA Senior Vice President, Partner Global Industry Analyst 34 years of professional experience	MBA St. John's University
Anne C. Gallo Senior Vice President & Partner Global Industry Analyst 17 years of professional experience	MS MIT Sloan School of Management
Jean H. Hynes, CFA Senior Vice President & Partner Global Industry Analyst 15 years of professional experience	BA Wellesley College
Kirk J. Mayer Vice President Global Industry Analyst 14 years of professional experience	MBA Wharton School of Finance at the University of Pennsylvania
Robert L. Deresiewicz Vice President Global Industry Analyst 21 years of Professional Experience

top of page ^

Prospectus

PDF Format

View Prospectus

Footnotes

The investment return and principal value of an investment will fluctuate so that shares, when redeemed, may be worth more or less than their original cost.

Non-diversified fund investments concentrated in a specific industry or sector may be subject to greater risks than traditional diversified equity funds.

A percentage of the Fund may be invested in securities of non-U.S. companies and/or non-dollar securities. Investing in foreign securities may involve different and additional risks associated with foreign currencies, investment disclosure, accounting, securities regulation, commissions, taxes, political or social instability, war or expropriation.

top of page ^